It is possible: availability of lymphedema case management in each health facility in Togo. Program description, evaluation, and lessons learned
- PMID: 23690550
 - PMCID: PMC3748474
 - DOI: 10.4269/ajtmh.12-0453
 
It is possible: availability of lymphedema case management in each health facility in Togo. Program description, evaluation, and lessons learned
Abstract
Lymphatic filariasis (LF) is a vector-borne parasitic disease that can clinically manifest as disabling lymphedema. Although the LF elimination program aims to reduce disability and to interrupt transmission, there has been a scarcity of disease morbidity management programs, particularly on a national scale. This report describes the implementation of the first nationwide LF lymphedema management program. The program, which was initiated in Togo in 2007, focuses on patient behavioral change. Its goal is two-fold: to achieve a sustainable program on a national-scale, and to serve as a model for other countries. The program has five major components: 1) train at least one health staff in lymphedema care in each health facility in Togo; 2) inform people with a swollen leg that care is available at their dispensary; 3) train patients on self-care; 4) provide a support system to motivate patients to continue self-care by training community health workers or family members and providing in home follow-up; and 5) integrate lymphedema management into the curriculum for medical staff. The program achieved the inclusion of lymphedema management in the routine healthcare package. The evaluation after three years estimated that 79% of persons with a swollen leg in Togo were enrolled in the program. The adherence rate to the proposed World Health Organization treatment of washing, exercise, and leg elevation was more than 70% after three years of the program, resulting in a stabilization of the lymphedema stage and a slight decrease in reported acute attacks among program participants. Health staff and patients consider the program successful in reaching and educating the patients. After the external funding ended, the morbidity management program is maintained through routine Ministry of Health activities.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
- 
    
- World Health Organization . Lymphatic Filariasis Fact Sheet No. 102. World Health Organization Media Center; 2012. http://www.who.int/mediacentre/factsheets/fs102/en/ Available at. Accessed May 1, 2012.
 
 - 
    
- World Health Organization The World Health Report: Changing History. 2004. http://www.who.int/whr/2004/en/ Available at. Accessed May 5, 2012.
 
 - 
    
- World Health Organization Managing morbidity and preventing disability in the global programme to eliminate lymphatic filariasis: WHO position statement. Wkly Epidemiol Rec. 2011;86:581–585. - PubMed
 
 - 
    
- Person B, Bartholomew LK, Gyapong M, Addiss D, van den Borne B. Health-related stigma among women with lymphatic filariasis from the Dominican Republic and Ghana. Soc Sci Med. 2009;68:30–38. - PubMed
 
 - 
    
- Richard S, Mathieu E, Addiss D, Sodahlon Y. A survey of treatment practices and burden of lymphoedema in Togo. Trans R Soc Trop Med Hyg. 2007;101:391–397. - PubMed
 
 
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
